PORTARIA Nº 6, DE 28 DE MAIO DE 2012

MINISTÉRIO DA SAÚDE; SECRETARIA DE CIÊNCIA, TECNOLOGIA E INSUMOS ESTRATÉGICOS.
DIARIO OFICIAL DO ESTADO DE SÃO PAULO ; Seção I(106): 84-84, jun. 01, 2012.
Artigo Português | SES SP - Acervo Centro de Referência e Treinamento DST/AIDS | ID: crt-7334

Documentos relacionados

  1. Disease progression in paediatric- and adult-onset sclerosing cholangitis: Results from two independent Dutch registries.
  2. Hepatocyte estrogen sulfotransferase inhibition protects female mice from concanavalin A-induced T cell-mediated hepatitis independent of estrogens.
  3. Discovery of adamantane-type polycyclic polyprenylated acylphloroglucinols that can prevent concanavalin A-induced autoimmune hepatitis in mice.
  4. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study.
  5. Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.
  6. Sex-related factors in autoimmune liver diseases.
  7. Association of TNF-α-308 Polymorphism with Susceptibility to Autoimmune Hepatitis in Tunisians.
  8. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.
  9. [Autoimmune hepatitis: 2021 update].
  10. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history.